, Grail sent 408 patients notifications "in error" that their bloodwork suggested they could have cancer.
It's a grave error that should give anybody pause before handing over sensitive medical data to a private biotech company.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more: